Biocon secures Yesintek biosimilar entry in nine more countries
Biocon has signed a licence agreement with Janssen Sciences Ireland that clears the way for Yesintek, its proposed biosimilar to Stelara (ustekinumab), in nine additional countries with immediate effect: Australia, Brazil, China,…
Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.